Company Overview
American HealthCare Capital is pleased to introduce a Founded in 2022 by four partners, Vitalink AI and headquartered in the Northwest. The company is a Digital Health Infrastructure in age technology and oncology (chronic disease care) Digital Health Services company which incorporates RPM (remote patient monitoring) by using wearable and ambient biosensors and data analytics.
The business is a C Corporation that is currently working with one medical provider network and have two networks pending.
Financial Overview
The business started in 2022 and is starting to see some growth. In their inaugural year of 2022 the team was making introductions and presenting their product. Traction was gained in 2023 and with one medical network on board, they are waiting on the decision of two more and the business development team has made significant progress thus far in 2024 with introductions and presentations to new potential clients and market-leading EMR integration with access to two million patients annually. Pending continued investment in business development. The year end revenue for 2024 under their goal of $250,000 and 2025 ended slightly higher at around $300,000.00.
Individuals who are 55+ and over 65 and at heightened risk of infections daily and more so in the next pandemic. There are over 9 million plus people who are immuno-compromised in the USA. Novel cancer treatments like immunotherapy require better at home health monitoring to detect early compromise. The demand for in-home care requires solutions to securely monitor patients and outbreaks without burden on health systems.
Solution:
Biosensors – these sensors meticulously chosen to fit senior and immunocompromised patients and continuously monitor key vital signs of the patient.
The AI technology changes in vitals trajectory and provides early indicators of deterioration.
This method of monitoring has proven 9X improved detection of actionable hypoxia alerts. This is based upon completed multi-site clinical studies.
Company Advantages:
The monitoring is device-agnostic including mass market products like Apple watch, Oura ring and FitBit. Vitalink also has special revenue sharing agreements with two top-of-its-class device manufacturers, particularly suited for senior care and chronic cancer care patients.
The monitoring is also EMR agnostic, with additional EMRs of choice able to be integrated as needed.
This method is Scalable and Cost effective using secure SaaS solutions integrated with EMR’s allow for rapid adoption in case of infectious disease outbreak or chronic use.
Method is Billable to insurance using current PRM/RTM codes.
Management will remain through transition: To facilitate a successful and orderly transition, the current owner is willing to remain with the Company during a transition period part time. The Co-founders will not stay but the software developers will stay, and advisors will support through the transition as well.
Growth Opportunities
The opportunities for growth can be achieved with targeted marketing and an increase in Business Development. Target large MSA’s with a big network of providers who have over 1500 / 2000 beds a month. Continue to utilize the strong network currently in place and industry relationships.to doctors who are not part of the program.
Asking Price
Asking price for the business is $550,000 dollars.
